Purpose: Stress urinary incontinence is a common disease with a devastating
impact on patient quality of life. Needle suspension procedures, which pro
duce disappointing long-term results for type II stress incontinence, are b
eing replaced by pubovaginal slings which previously were reserved solely f
or the treatment of type III stress incontinence. We report the long-term o
utcomes of pubovaginal slings for the treatment of types II and III stress
urinary incontinence, and assess its quality of life impact.
Materials and Methods: From January 1993 until December 1996, 247 females 1
0 to 84 years old (mean age 54.5) with type II (54%) or III (46%) stress ur
inary incontinence diagnosed by fluoroscopic urodynamics received a pubovag
inal sling. Concomitant urge incontinence was present in 109 patients (44%)
. Quality of life was assessed with the Urogenital Distress Inventory short
form.
Results: At a mean followup of 51 months (range 22 to 68) the continence ra
tes were 88% overall, 91% for type II and 84% for type III. Preoperative ur
ge incontinence resolved in 81 of 109 patients (74%), while de novo urge in
continence developed in 10 (7%). Intermittent urethral catheterization dura
tion averaged 8.4 days, with 5 women undergoing urethrolysis for a hyper-su
spended urethra. Secondary procedures were required in 9 patients with type
II and 5 with type III incontinence, and included transurethral collagen i
njections in 6 and repeat pubovaginal slings in 8. There was a 4% complicat
ion rate due to pelvic hematoma in 2 cases, incisional hernia in 2, deep ve
nous thrombosis in 1 and pulmonary embolus in 1. Of the 247 patients 235 (9
5%) completed the quality of life questionnaire with 92% reporting a high d
egree of satisfaction with low (less than 20 of 100 points) symptom distres
s scores.
Conclusions: Pubovaginal slings are effective and durable, and significantl
y improve quality of life in patients with types II and III stress urinary
incontinence.